CHMP Backs Generic Lopinavir/Ritonavir Mylan for HIVCHMP Backs Generic Lopinavir/Ritonavir Mylan for HIV

Studies demonstrate the satisfactory quality of Lopinavir/Ritonavir Mylan and its bioequivalence to the reference product Kaletra, the committee said. International Approvals

Source: Medscape Medical News Headlines - November 20, 2015 Category: Consumer Health News Tags: HIV/AIDS News Alert Source Type: news